A Novel Diagnostic Option for Biochemically Recurrent Prostate Cancer Diagnosis - Part 1
We now have some new weapons in our prostate cancer arsenal. In part 1 of this video presentation, the speaker will discuss the origin of prostate cancer and some of the new diagnostic tools and treatment options available to fight this disease. The topics will include the background of prostate cancer, treatment options and considerations, biochemical recurrence, treatment options for biochemical recurrence, and a discussion Axumin (fluciclovine F18).
By the end of this session, the attendee will be able to: Describe the background of prostate cancer imaging. List the treatment options, considerations, and biochemical recurrence available for prostate cancer patients. State the purpose of the radiopharmaceutical Axumin and how it contributes to prostate cancer patient outcomes. A Novel Diagnostic Option for Biochemically Recurrent Prostate Cancer Diagnosis Part 1 The attendee should now be able to: Describe the background of prostate cancer imaging. List the treatment options, considerations, and biochemical recurrence available for prostate cancer patients. State the purpose of the radiopharmaceutical Axumin and how it contributes to prostate cancer patient outcomes. Select the link below to launch the video in a separate window. Webinar Video
- Biochemically Recurrent Prostate Cancer Diagnosis